The authors offer recommendations for permissible daily exposures and concentration limits of elemental impurities for dermal drug products.
Anne-Pascale Luzy
Advertisement
Anne-Pascale Luzy is head of in vitro toxicology at Nestle Skin Health.
Articles by Anne-Pascale Luzy
Advertisement
Latest Updated Articles
Determination of Dermal PDE for Pharmaceutical ProductsPublished: January 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops
2
Live Cell High-Content Imaging is Driving Drug Discovery
3
FAQ: Pharmaceutical Outsourcing Trends and Innovations
4
FAQ: Everything to Know about 3D Printing in Pharma Manufacturing and Packaging
5
